News | October 01, 2009

Invatec Launches REEF HP PTA Balloon Catheter in Europe


October 1, 2009 – Invatec recently launched the REEF HP PTA Balloon Catheter at CIRSE 2009, which the company said is ideal for use in all peripheral high-pressure dilatation procedures.

The “lesion-specific” design of the balloon material is particularly useful in “hard-to-dilate” situations and the availability of variable shaft lengths mean that the Reef HP is equally suited to both arterio-venous shunts (50 cm shaft), and peripheral applications (80/120 cm shaft).

The company said the REEF HP is a robust and highly stable balloon, capable of counter-acting even the most severe arterial lesions, with minimal slippage and a high pressure threshold. The “lesion-specific” design is ideal for use in dialysis patients whose AV shunts often create short, fibrous, and hard-to-dilate lesions where the shunt is connected to the native vessel.

The REEF HP balloon is made from Invatec’s proprietary FLEXITEC XF, an extremely durable material with a large working pressure range of up to 22 bar, offering complete control during high pressure procedures. It is also a low compliant balloon, offering a uniform dilatation force and strong shape retention to dilate resistive lesions with greater success and extreme stability.

For more information: www.invatec.com


Related Content

News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
News | Balloon Catheter

July 15, 2019 — Edwards LifeSciences is recalling the IntraClude Intra-Aortic Occlusion Device due to a risk of balloon ...

Home July 15, 2019
Home
Subscribe Now